Oncology (TOI) Soars 10.65% on Insider Buying

The Oncology (TOI) surged 10.65% today, marking its third consecutive day of gains, with a cumulative increase of 25.79% over the past three days. The share price reached its highest level since January 2024, with an intraday gain of 11.57%.

Recent insider transactions have played a significant role in driving TOI's stock price. Over the past month, all executives, including the CEO, collectively acquired 1.6 million shares in a series of purchases. This cluster buying has led to a surge in the stock price, reflecting strong confidence from the company's leadership. The insider buying has been a pivotal factor in the stock's dramatic increase, indicating a positive outlook from those closest to the company's operations and future prospects.